[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Asia Pacific Genetic Testing Services Market Forecast to 2030 - Regional Analysis - by Service Type (Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, and Others), Disease (Cancer, Metabolic Diseases, Cardiovascular Diseases, and Other Diseases), and Service Provider (Hospital-Based Laboratories, Diagnostic Laboratories, and Others)

June 2024 | 97 pages | ID: AD5416263236EN
The Insight Partners

US$ 3,550.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Asia Pacific genetic testing services market was valued at US$ 646.31 million in 2022 and is expected to reach US$ 2,156.88 million by 2030; it is estimated to register a CAGR of 16.3% from 2022 to 2030.

Untapped Emerging Markets in Developing Countries Boost Asia Pacific Genetic Testing Services Market

Emerging countries such as China, India, Brazil, and Mexico offer significant growth opportunities to market players. The high growth can majorly be attributed to the increasing public healthcare expenditure, improving healthcare infrastructure, and the presence of a large target patient population. The need for genetic testing has also increased owing to a rise in awareness of genetic disorders in developing economies and their early diagnosis. The ease and applicability of genetic testing procedures have benefitted R&D activities in developing regions worldwide. Major market players are focusing on strategies and initiatives, such as agreements, collaborations, partnerships, and expansions, to improve their product availability, accessibility, and distribution networks in these countries, as it will help them address the growing need for early diagnosis and treatment. For instance, in 2023, Progenesis, a well-known international genetic testing company with its headquarters in the US, has opened its first Genetic Laboratory in New Delhi and its AI & Bioinformatics Data Center in Chennai, marking the company's official entry into the Indian market. The Chinese government identifies genomics as an important strategic field in its 14th Five-Year Plan (2016-2020) for the country's economic and social development. In 2016, the Chinese Academy of Sciences launched the Precision Medicine Initiative, a 14-year project worth US$ 9.2 billion to sequence more than 100 million human genomes by 2030. In December 2017, China's Ministry of Science and Technology collaborated with a human genome research project to document the genetic makeup of 100,000 people. Using the genetic data of nine different minority groups, researchers desire to decode hereditary information within genes. In addition, rising consumer awareness regarding DTC genetic tests in developing economies offers growth opportunities to the DTC industry. Therefore, emerging markets in developing countries are expected to offer significant opportunities to the players operating in the market and boost the market growth during the forecast period.

Asia Pacific Genetic Testing Services Market Overview

The Asia Pacific genetic testing services market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth is driven by a large pool of patients living with genetic conditions and increasing investments by the governments of the respective countries in the region. An increase in affordability, surge in healthcare expenditure, and rise in awareness toward early screening of genetic disorders are expected to fuel the market growth in the forecast period. In addition, the rise in the development and research for genomics and the rise in the programs for genomics further augment the market growth.

Asia Pacific Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Genetic Testing Services Market Segmentation

The Asia Pacific genetic testing services market is categorized into service type, disease, service provider, and country.

Based on service type, the Asia Pacific genetic testing services market is segmented predictive testing, carrier testing, prenatal testing, newborn screening, and others. The predictive testing segment held the largest market share in 2022.

In terms of disease, the Asia Pacific genetic testing services market is categorized into cancer, metabolic diseases, cardiovascular diseases, and other diseases. The cancer segment held the largest market share in 2022.

By service provider, the Asia Pacific genetic testing services market is segmented into hospital-based laboratories, diagnostic laboratories, and others. The hospital-based laboratories segment held the largest market share in 2022.

By country, the Asia Pacific genetic testing services market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific genetic testing services market share in 2022.

Eurofins Scientific SE, Exact Sciences Corp, Laboratory Corp of America Holdings, Quest Diagnostics Inc, Illumina Inc, F. Hoffmann-La Roche Ltd, and Centogene AG are among the leading companies operating in the Asia Pacific genetic testing services market.
1. INTRODUCTION

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. EXECUTIVE SUMMARY

2.1 Key Insights

3. RESEARCH METHODOLOGY

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. ASIA PACIFIC GENETIC TESTING SERVICES MARKET - KEY INDUSTRY DYNAMICS

4.1 Key Market Drivers
  4.1.1 Rising Prevalence of Genetic Diseases
  4.1.2 Increasing Awareness and Acceptance of Personalized Medicines
  4.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
4.2 Market Restraints
  4.2.1 Social and Ethical Implications of Genetic Testing
  4.2.2 Affordability of Genetic Services
4.3 Market Opportunities
  4.3.1 Untapped Emerging Markets in Developing Countries
4.4 Future Trends
  4.4.1 Artificial Intelligence-Powered Genetic Testing
4.5 Impact Analysis:

5. GENETIC TESTING SERVICES MARKET - ASIA PACIFIC MARKET ANALYSIS

5.1 Asia Pacific Genetic Testing Services Market Revenue (US$ Mn), 2022 - 2030

6. ASIA PACIFIC GENETIC TESTING SERVICES MARKET - REVENUE AND FORECAST TO 2030 - BY SERVICE TYPE

6.1 Overview
6.2 Asia Pacific Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
6.3 Predictive Testing
  6.3.1 Overview
  6.3.2 Predictive Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Carrier Testing
  6.4.1 Overview
  6.4.2 Carrier Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Prenatal Testing
  6.5.1 Overview
  6.5.2 Prenatal Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Newborn Screening
  6.6.1 Overview
  6.6.2 Newborn Screening: Asia Pacific Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
  6.7.1 Overview
  6.7.2 Others: Asia Pacific Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

7. ASIA PACIFIC GENETIC TESTING SERVICES MARKET - REVENUE AND FORECAST TO 2030 - BY DISEASE

7.1 Overview
7.2 Asia Pacific Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
7.3 Cancer
  7.3.1 Overview
  7.3.2 Cancer: Asia Pacific Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
  7.4.1 Overview
  7.4.2 Cardiovascular Diseases: Asia Pacific Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Metabolic Diseases
  7.5.1 Overview
  7.5.2 Metabolic Diseases: Asia Pacific Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Other Diseases
  7.6.1 Overview
  7.6.2 Other Diseases: Asia Pacific Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. ASIA PACIFIC GENETIC TESTING SERVICES MARKET - REVENUE AND FORECAST TO 2030 - BY SERVICE PROVIDER

8.1 Overview
8.2 Asia Pacific Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
8.3 Hospital-Based Laboratories
  8.3.1 Overview
  8.3.2 Hospital-Based Laboratories: Asia Pacific Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Diagnostic Laboratories
  8.4.1 Overview
  8.4.2 Diagnostic Laboratories: Asia Pacific Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Others
  8.5.1 Overview
  8.5.2 Others: Asia Pacific Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. ASIA PACIFIC GENETIC TESTING SERVICES MARKET - COUNTRY ANALYSIS

9.1 Asia Pacific
  9.1.1 Asia Pacific Genetic Testing Services Market, by Country
    9.1.1.1 China
      9.1.1.1.1 Overview
      9.1.1.1.2 China Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
      9.1.1.1.3 China Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
      9.1.1.1.4 China Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
      9.1.1.1.5 China Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
    9.1.1.2 Japan
      9.1.1.2.1 Overview
      9.1.1.2.2 Japan Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
      9.1.1.2.3 Japan: Asia Pacific Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
      9.1.1.2.4 Japan: Asia Pacific Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
      9.1.1.2.5 Japan: Asia Pacific Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
    9.1.1.3 India
      9.1.1.3.1 Overview
      9.1.1.3.2 India Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
      9.1.1.3.3 India Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
      9.1.1.3.4 India Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
      9.1.1.3.5 India Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
    9.1.1.4 Australia
      9.1.1.4.1 Overview
      9.1.1.4.2 Australia Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
      9.1.1.4.3 Australia Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
      9.1.1.4.4 Australia Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
      9.1.1.4.5 Australia Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
    9.1.1.5 South Korea
      9.1.1.5.1 Overview
      9.1.1.5.2 South Korea Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
      9.1.1.5.3 South Korea Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
      9.1.1.5.4 South Korea Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
      9.1.1.5.5 South Korea Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
    9.1.1.6 Rest of Asia Pacific
      9.1.1.6.1 Overview
      9.1.1.6.2 Rest of Asia Pacific Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
      9.1.1.6.3 Rest of Asia Pacific Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
      9.1.1.6.4 Rest of Asia Pacific Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
      9.1.1.6.5 Rest of Asia Pacific Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)

10. GENETIC TESTING SERVICES MARKET-INDUSTRY LANDSCAPE

10.1 Overview
10.2 Growth Strategies in Genetic Testing Services Market
10.3 Organic Growth Strategies
  10.3.1 Overview
10.4 Inorganic Growth Strategies
  10.4.1 Overview

11. COMPANY PROFILES

11.1 Eurofins Scientific SE
  11.1.1 Key Facts
  11.1.2 Business Description
  11.1.3 Products and Services
  11.1.4 Financial Overview
  11.1.5 SWOT Analysis
  11.1.6 Key Developments
11.2 Exact Sciences Corp
  11.2.1 Key Facts
  11.2.2 Business Description
  11.2.3 Products and Services
  11.2.4 Financial Overview
  11.2.5 SWOT Analysis
  11.2.6 Key Developments
11.3 Laboratory Corp of America Holdings
  11.3.1 Key Facts
  11.3.2 Business Description
  11.3.3 Products and Services
  11.3.4 Financial Overview
  11.3.5 SWOT Analysis
  11.3.6 Key Developments
11.4 Quest Diagnostics Inc
  11.4.1 Key Facts
  11.4.2 Business Description
  11.4.3 Products and Services
  11.4.4 Financial Overview
  11.4.5 SWOT Analysis
  11.4.6 Key Developments
11.5 Illumina Inc
  11.5.1 Key Facts
  11.5.2 Business Description
  11.5.3 Products and Services
  11.5.4 Financial Overview
  11.5.5 SWOT Analysis
  11.5.6 Key Developments
11.6 F. Hoffmann-La Roche Ltd
  11.6.1 Key Facts
  11.6.2 Business Description
  11.6.3 Products and Services
  11.6.4 Financial Overview
  11.6.5 SWOT Analysis
  11.6.6 Key Developments
11.7 Centogene AG
  11.7.1 Key Facts
  11.7.2 Business Description
  11.7.3 Products and Services
  11.7.4 Financial Overview
  11.7.5 SWOT Analysis
  11.7.6 Key Developments

12. APPENDIX

12.1 About Us
12.2 Glossary of Terms


More Publications